Stone Gregg W, Webb John, Cox David A, Brodie Bruce R, Qureshi Mansoor, Kalynych Anna, Turco Mark, Schultheiss Heinz P, Dulas Daniel, Rutherford Barry D, Antoniucci David, Krucoff Mitchell W, Gibbons Raymond J, Jones Denise, Lansky Alexandra J, Mehran Roxana
Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10022, USA.
JAMA. 2005 Mar 2;293(9):1063-72. doi: 10.1001/jama.293.9.1063.
Atheromatous and thrombotic embolization during percutaneous coronary intervention (PCI) in acute myocardial infarction is common and may result in microcirculatory dysfunction, the prevention of which may improve reperfusion success, reduce infarct size, and enhance event-free survival.
To determine whether protection of the distal microcirculation from thromboembolic debris liberated during primary PCI results in improved reperfusion and decreased infarct size.
DESIGN, SETTING, AND PATIENTS: Prospective randomized controlled trial at 38 academic and community-based institutions in 7 countries enrolling 501 patients aged 18 years or older with ST-segment elevation myocardial infarction (STEMI) presenting within 6 hours of symptom onset and undergoing primary PCI or rescue intervention after failed thrombolysis.
Patients were randomized between May 20, 2002, and November 21, 2003, to receive PCI with a balloon occlusion and aspiration distal microcirculatory protection system vs angioplasty without distal protection.
Coprimary end points were ST-segment resolution (STR) measured 30 minutes after PCI by continuous Holter monitoring and infarct size measured by technetium Tc 99m sestamibi imaging between days 5 and 14. Secondary end points included major adverse cardiac events.
Among 252 patients assigned to distal protection, aspiration was performed in 97% (242/251), all angioplasty balloon inflations were fully protected in 79% (193/245), and visible debris was retrieved from 73% (182/250). Complete STR was achieved in a similar proportion reperfused with vs without distal protection (63.3% [152/240] vs 61.9% [148/239], respectively; absolute difference, 1.4% [95% confidence interval, -7.7% to 10.5%; P = .78]), and left ventricular infarct size was similar in both groups (median, 12.0% [n = 229] vs 9.5% [n = 208], respectively; P = .15). Major adverse cardiac events at 6 months occurred with similar frequency in the distal protection and control groups (10.0% vs 11.0%, respectively; P = .66).
A distal balloon occlusion and aspiration system effectively retrieves embolic debris in most patients with acute STEMI undergoing emergent PCI. Nonetheless, distal embolic protection did not result in improved microvascular flow, greater reperfusion success, reduced infarct size, or enhanced event-free survival.
急性心肌梗死患者经皮冠状动脉介入治疗(PCI)期间的动脉粥样硬化和血栓栓塞很常见,可能导致微循环功能障碍,预防这种情况可能会提高再灌注成功率、减小梗死面积并提高无事件生存率。
确定在直接PCI期间保护远端微循环免受血栓栓塞碎片的影响是否能改善再灌注并减小梗死面积。
设计、地点和患者:一项前瞻性随机对照试验,在7个国家的38个学术和社区机构进行,纳入了501例年龄在18岁及以上、症状发作6小时内出现ST段抬高型心肌梗死(STEMI)且在溶栓失败后接受直接PCI或补救干预的患者。
患者在2002年5月20日至2003年11月21日期间被随机分组,分别接受使用球囊闭塞和抽吸远端微循环保护系统的PCI或无远端保护的血管成形术。
共同主要终点是PCI后30分钟通过连续动态心电图监测测量的ST段回落(STR)以及在第5天至第14天之间通过锝Tc 99m甲氧基异丁基异腈成像测量的梗死面积。次要终点包括主要不良心脏事件。
在分配到远端保护组的252例患者中,97%(242/251)进行了抽吸,79%(193/245)的所有血管成形术球囊充气均得到充分保护,73%(182/250)的患者取回了可见碎片。在接受远端保护和未接受远端保护而再灌注的患者中,完全STR的比例相似(分别为63.3%[152/240]和61.9%[148/239];绝对差异为1.4%[95%置信区间,-7.7%至10.5%;P = 0.78]),两组的左心室梗死面积相似(中位数分别为12.0%[n = 229]和9.5%[n = 208];P = 0.15)。远端保护组和对照组在6个月时发生主要不良心脏事件的频率相似(分别为10.0%和11.0%;P = 0.66)。
远端球囊闭塞和抽吸系统能有效在大多数接受紧急PCI的急性STEMI患者中取回栓塞碎片。尽管如此,远端栓塞保护并未改善微血管血流、提高再灌注成功率、减小梗死面积或提高无事件生存率。